alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › amyloid-burden

amyloid-burden

8 studies tagged amyloid-burden, dated 2016-01-26 to 2025-01-14. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease 2025-01-14
  2. The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-β burden 2023-02-20
  3. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients 2022-09-08

Studies

8 studies carry this tag.

Date range

2016 to 2025

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • American journal of respiratory and critical care medicine 1
  • CNS neuroscience & therapeutics 1
  • Journal of neurology 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-01-14 Biomarkers

    Risk stratification for PET Aβ+ based on a plasma p-tau217 assay demonstrated potential diagnostic and prognostic utility in an Asian cohort with concomitant CeVD.

  2. The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-β burden

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of neurology 2023-02-20 Biomarkers

    We aimed to investigate the association of subjective sleep characteristics and plasma Alzheimer's disease (AD) biomarkers in older cognitively unimpaired adults with higher amyloid-β (Aβ) burden.

  3. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. CNS neuroscience & therapeutics 2022-09-08 Biomarkers

    Our findings highlight that plasma p-tau181, alone or combined with NfL, contributes to identifying high-risk AD populations.

  4. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Science advances 2022-04-01 Biomarkers

    CD22 has been suggested to contribute to Alzheimer's disease (AD) pathogenesis by inhibiting microglial amyloid β (Aβ) phagocytosis.

  5. Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Journal of Alzheimer's disease : JAD 2022-01-01 Biomarkers

    In cognitively unimpaired adults, elevated plasma p-tau181 is associated with future increased Aβ deposition across multiple brain regions.

  6. Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of Alzheimer's disease : JAD 2021-01-01 Biomarkers

    The developed model based on serum biomarkers and other co-variates could reflect the AD core pathology.

  7. Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. American journal of respiratory and critical care medicine 2018-04-01 Tau biomarkers

    In a sample of cognitively normal elderly, OSA was associated with markers of increased amyloid burden over the 2-year follow-up.

  8. Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Translational psychiatry 2016-01-26 Biomarkers

    We believe this is the first study to investigate associations between blood metabolites and neocortical amyloid burden (NAB) in the search for a blood-based biomarker for Alzheimer's disease (AD).

All topic tags with their study counts